The cardiovascular and renal effects of acute and chronic inhibition of nitric oxide production in fetal sheep

被引:3
|
作者
Yu, ZY [1 ]
Lumbers, ER [1 ]
Simonetta, G [1 ]
机构
[1] Univ New S Wales, Sch Med Sci, Dept Physiol & Pharmacol, Sydney, NSW 2052, Australia
关键词
D O I
10.1113/eph8702339
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The acute and long-term effects of blockade of nitric oxide (NO) production were studied in six chronically catheterised fetal sheep aged from 116 and 118 days; six untreated fetal sheep received injections of saline. Injection of 10 mg (kg maternal body wt)(-1) of the nitric oxide synthase (NOS) inhibitor N-omega-nitro-L-arginine (NOLA) to the fetus, caused an immediate rise in fetal mean arterial pressure (MAP, P < 0.005) and a reflex fall in fetal heart rate (FHR, P < 0.001). Plasma renin concentration (PRC) fell from 8.4 +/- 3.3 to 1.5 +/- 0.3 ng ml(-1) h(-1) (P < 0.001) and was dependent on MAP (P = 0.001). Glomerular filtration rate (GFR) tended to increase, but renal blood flow (RBF) velocity decreased (P < 0.001). Thus filtration fraction (FF) increased (P < 0.025). Urine flow and sodium excretion increased (P < 0.001 for both). Fractional sodium reabsorption decreased (P < 0.05). In fetuses treated with NOLA, arterial pressure was found to affect glomerular haemodynamics and renal tubular handling of sodium. No such relationships were observed in untreated fetuses. The vascular responses to acetylcholine tended to be less (P = 0.07) and the responses to noradrenaline were enhanced in NOLA-treated fetuses. There were no changes in untreated fetuses. Fetuses were then injected twice daily with either 5 mg kg(-1) NOLA or saline for the next 2 days. On the 4th day, injection of 10 mg kg(-1) NOLA did not have any effects on MAP, FHR or renal function. However, the pressor responses to angiotensin II (Ang II) were enhanced (P < 0.005), as was the response to noradrenaline but to a lesser extent. It is concluded that endothelial production of NO maintains normal fetal blood pressure, renal vascular resistance and fetal renal function. When NO production was blocked by repeated injections of NOLA, other vasodilator pathways took over the maintenance of cardiovascular and renal vascular tone. However, alterations in both cardiovascular and renal function were still present. That is, there was increased pressor sensitivity to exogenous Ang II and unmasking of effects of arterial pressure on glomerular and tubular function.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 50 条
  • [31] Effects of zaprinast and dissolved nitric oxide on the pulmonary circulation of fetal sheep
    Skimming, JW
    DeMarco, VG
    Kadowitz, PJ
    Cassin, S
    PEDIATRIC RESEARCH, 1996, 39 (02) : 223 - 228
  • [32] Renal and cardiovascular effects of renal denervation in conscious rats after adenosine administration and nitric oxide synthase inhibition
    Girchev, R
    Mikhov, D
    Markova, P
    KIDNEY & BLOOD PRESSURE RESEARCH, 2002, 25 (04): : 217 - 223
  • [33] Effects of acute and chronic inhibition of nitric oxide synthase on brown adipose tissue thermogenesis
    Saha, SK
    Ohinata, H
    Kuroshima, A
    JAPANESE JOURNAL OF PHYSIOLOGY, 1996, 46 (05): : 375 - 382
  • [34] Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system
    Scrogin, KE
    Hatton, DC
    Chi, Y
    Luft, FC
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1998, 274 (02) : R367 - R374
  • [35] Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis
    Roberts, F
    Roberts, CW
    Ferguson, DJP
    McLeod, R
    PARASITE IMMUNOLOGY, 2000, 22 (01) : 1 - 5
  • [36] Inhibition of nitric oxide synthase by isothioureas: Cardiovascular and antinociceptive effects
    Handy, RLC
    Wallace, P
    Moore, PK
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 55 (02) : 179 - 184
  • [37] Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase
    Kukreja, R. C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (05) : 538 - 540
  • [38] Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis
    Lecian, Dalibor
    Demova, Hana
    Lodererova, Alena
    Zdychova, Jana
    Kluckova, Hana
    Teplan, Vladamir
    Voska, Ludek
    komers, Radko
    KIDNEY & BLOOD PRESSURE RESEARCH, 2006, 29 (03): : 135 - 143
  • [39] Nitric oxide production is reduced in patients with chronic renal failure
    Wever, R
    Boer, P
    Hijmering, M
    Stroes, E
    Verhaar, M
    Kastelein, J
    Versluis, K
    Lagerwerf, F
    van Rijn, H
    Koomans, H
    Rabelink, T
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (05) : 1168 - 1172
  • [40] Low nitric oxide production in patients with chronic renal failure
    Blum, M
    Yachnin, T
    Wollman, Y
    Chernihovsky, T
    Peer, G
    Grosskopf, I
    Kaplan, E
    Silverberg, D
    Cabili, S
    Iaina, A
    NEPHRON, 1998, 79 (03): : 265 - 268